Biocryst Pharmaceuticals Inc (BCRX)

EBITDA Growth

247.54%

Quarterly · Period ending:

BCRX logo

BCRX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported247.54%
BCRX Quarterly EBITDA YoY % (-107.69% → 247.54%)
High-resolution chart · PNG

BCRX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
247.5402%
-2,947.3661%
21,689.2944%
174.7691%
126.2529%
340.9626%
96.7685%
245.1701%
127.7284%
58.9638%
14.4695%
49.1348%
-34.5301%
50.0412%
-1,402.5109%
64.3836%
-14.0388%
2.8104%
106.261%
-4.0928%
16.9042%
-49.1291%
-8,516%
-24.2769%
-3.1761%
-21.9594%
102.6189%
-27.018%
-114.2777%
-20.4621%
-44.892%
-111.1111%
-9.8495%
-95.614%
-678.6364%
-29.6117%
1.0223%
37.1244%
87.0786%
24.8746%
-373.9937%
-37.6485%
-65.0126%
-76.1038%
140.2915%
-56.1185%
-149.8305%
-8.9346%
-22.5163%
-173.8309%
43.1834%
12.9315%
0.3467%
31.6469%
88.6362%
37.5594%
21.8498%
58.0983%
-600.0499%
-18.1427%
-41.1901%
-382.207%
-159.0219%
-3.6785%
-19.289%
73.9557%
50.7812%
-12.4045%
35.9341%
34.2055%
465.3427%
20.8804%
-77.1055%
-1,822.2316%
73.2593%
28.8828%
32.0367%
91.7099%
-44.3576%
-111.2566%
-88.9239%
-52.7292%
-27.8716%
-47.9754%
-14.575%
-3.834%
-89.6541%
-65.2188%
-68.6275%
-117.351%
-23.5822%
-1.5781%
39.6942%
53.3871%
-5.3827%
-2,226.7123%
-1,708.1967%
-128.6143%
54.5332%
108.1111%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.